Safety and efficacy of obinutuzumab with CHOP or bendamustine in previously untreated follicular lymphoma

The GAUDI study assessed safety and preliminary efficacy of induction therapy with obinutuzumab plus chemotherapy, followed by maintenance therapy with obinutuzumab alone, in previously untreated patients with follicular lymphoma. Assignment to chemotherapy was decided on a per-center basis before t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Haematologica
Autores principales: Grigg, Andrew, Dyer, Martin J.S., Díaz, Marcos González, Dreyling, Martin, Rule, Simon, Lei, Guiyuan, Knapp, Andrea, Wassner-Fritsch, Elisabeth, Marlton, Paula
Formato: Artigo
Lenguaje:Inglês
Publicado: Ferrata Storti Foundation 2017
Materias:
Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5395117/
https://ncbi.nlm.nih.gov/pubmed/28011903
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2016.152272
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares